Approval · Notice of Compliance 29187 · 2022
MINT-MEMANTINE: Notice of Compliance 29187
Issued October 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29187
- Date
- October 13, 2022
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- EBIXA (Lundbeck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-MEMANTINE | 02531887 | Marketed |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB